Zonisamide Capsule
Product Images NDC 80425-0392

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 80425-0392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zonisamide 100mg #30 (Zonisamide 100mg 80425 0392 01)

Zonisamide 100mg #30 (Zonisamide 100mg 80425 0392 01)
Zonisamide 100 mg capsule packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label features the product name, strength, dosage form (capsule), and NDC 80425-0392-01. Additional details include lot number and expiration date 12/31/2025, along with a reference to brand ZONEGRAN and source NDC 72578-0042-01.*
FDA Label Image

Zonisamide 100mg # 60 (Zonisamide 100mg 80425 0392 02)

Zonisamide 100mg # 60 (Zonisamide 100mg 80425 0392 02)
Zonisamide 100 mg capsule packaging label from Advanced Rx Pharmacy of Tennessee, LLC, displaying a quantity of 60 capsules. The label includes a comparison to Zonegran and shows storage instructions (20°-25°C). It also contains a barcode and lot expiration details.*
FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 01)

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 01)
Chemical structure of zonisamide depicted as a 1,2-benzisoxazole ring with a sulfonamide group (CH2SO2NH2) attached, representing the active ingredient zonisamide.*
FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)
A line graph comparing percentage reduction in all partial seizures rate between patients treated with Zonisamide capsules and placebo. The x-axis shows the percentage of patients and the y-axis shows percentage reduction in seizures, with directions for improvement and worsening noted. Two lines represent treatment arms, one for Zonisamide capsules and one for placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.